Latest Syndromes Stories
Acquisition brings Shire a new phase 3 compound being investigated for the signs and symptoms of Dry Eye Disease LEXINGTON, Massachusetts, March 25, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it will acquire SARcode Bioscience Inc., a privately held biopharmaceutical company based in Brisbane, California. This acquisition continues to build Shire's presence in the ophthalmology therapeutic category and brings a new phase 3 compound -...
Fragile X syndrome is the most common inherited cause of intellectual disability and autism AUSTIN, Texas, March 21, 2013 /PRNewswire/ -- Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter(®) can improve the determination of a woman's risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing...
March 21 is World Down Syndrome Day. The Jérôme Lejeune Foundation, USA is proud to join with disability advocacy associations from 11 nations in an international campaign to say together: Down Syndrome - So What! http://www.downsyndrome-sowhat.eu Philadelphia, PA (PRWEB) March 20, 2013 The Jérôme Lejeune Foundation, USA is proud to join with disability advocacy associations from 11 nations (Spain, Portugal, Croatia, the United-Kingdom, Italy, Germany, Poland, Latvia...
Data from a non-interventional, observational study of 76 patients presented at the 65th American Academy of Neurology Annual Meeting ATLANTA, March 19, 2013 /PRNewswire/ -- UCB today announced data from a non-interventional, observational study conducted in Germany that found that when Parkinson's disease (PD) patients were switched from an oral PD medication to Neupro(®) (Rotigotine Transdermal System), they reported improvements in pre-existing gastrointestinal (GI) symptoms....
WASHINGTON, March 14, 2013 /PRNewswire-USNewswire/ -- The leader of the nation's largest wartime veterans service organization is expressing "great concern" over allegations that the Department of Veterans Affairs has grossly mishandled the care of Gulf War Illness patients. In testimony this week before the House Committee on Veterans' Affairs Subcommittee on Oversight and Investigations, several witnesses claimed that VA has consistently failed to treat the multi-symptomatic...
Great Taste No Pain is the latest program created by Sherry Brescia, who promises to give people an IBS diet plan to help them treat the digestive problem effectively. A full Great Taste No Pain review from the site HealthReviewCenter.com shows if the program is helpful for users to use. Seattle, WA (PRWEB) March 11, 2013 Great Taste No Pain is the newest achievement of Sherry Brescia, who claims to give people the IBS diet plan to help them eliminate the problem of irritable bowel...
Dr. Jacqueline Muller has shown that treating keratitis sicca (dry eye) can improve the quality of the ocular surface of a patient’s eyes, decreasing their eyestrain, thus decreasing the frequency and severity of that person’s headaches. New York City, New York (PRWEB) March 08, 2013 Dr. Jacqueline Muller has shown that treating keratitis sicca (dry eye) can improve the quality of the ocular surface of a patient’s eyes, decreasing their eyestrain, thus decreasing the frequency and...
April Flowers for redOrbit.com - Your Universe Online A new brain imaging study from Oxford University reveals that the phantom pain many amputees feel in the missing limb is linked to changes in the brain that occur following amputation. Arm amputees who maintained strong representations of the missing hand in their brains – to the point where it was indistinguishable from persons with both hands – experienced the most phantom limb pain. The research team hopes that their...
SAN FRANCISCO, March 4, 2013 /PRNewswire-USNewswire/ -- The sequester, with its devastating cuts to virtually every line item in the federal budget, is now forcing our nation to take a troubling step backward in the fight against HIV/AIDS. The cuts mean fewer chances for people to learn their HIV status, get the medical care they need to stay healthy, and avoid passing the virus on to others. It is now incumbent upon Congress to restore these funds as quickly as possible to minimize...
This study is a Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of a new drug in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS). Orlando, FL (PRWEB) February 28, 2013 Avail Clinical Research is now enrolling for an Irritable Bowel Syndrome Clinical Trial in Florida. To get started, visit Avail Clinical Research or call us directly at (386) 310-1334. Irritable bowel syndrome (IBS) is a...
